From GlobeNewswire: 2024-11-11 09:00:00

The Pharmaceutical Gelatin Market was valued at USD 1.69 Billion in 2023 and is projected to reach USD 2.79 Billion by 2032, with a 5.77% CAGR. The global pharmaceutical R&D expenditure was $300 billion in 2023, driving growth in drug formulation and delivery technologies.

As plant-based diets gain traction, there is a shift towards vegan-friendly gelatin products. The global market for plant-based protein options is nearly USD 25 billion, with around 70% of consumers associating plant-based options with healthier elements. Pharmaceutical companies are focusing on creating plant-based alternatives, driving the demand for pharmaceutical gelatin.

The rapid growth of the food and cosmetic industries is fueling increased demand for gelatin, especially in confectionery, dairy products, and beauty formulations. With the global beauty market valued at USD 446 billion in 2023, gelatin plays a crucial role in fulfilling consumer needs across multiple segments, driving market growth.

The pharmaceutical and nutraceutical industries are driving the rising demand for gelatin-based solutions, especially in capsule, tablet, and drug delivery applications. Gelatin’s digestibility and facilitation of improved bioavailability make it essential for dietary supplements and functional foods, driving market growth globally.

Type B gelatin accounted for 63% of the market share in 2023 due to its wide application in soft and hard capsules, stability, and consistency in pharmaceutical applications. Type A porcine gelatin is expected to have the highest CAGR of 6.39% from 2024-2032, due to its gelling strength and extensive usage in developing countries.

Stabilizing agents held the majority share of 47% in the Pharmaceutical Gelatin Market in 2023, ensuring the stability and shelf life of gelatin-based pharmaceutical products. Gelling agents and functional additives are projected to grow at a CAGR of 6.83% from 2024-2032, with innovations in gelling strength and demand for multifunctional products in pharmaceutical formulations.

North America led the Microfluidics Market in 2023, capturing 42% of the market share, driven by the pharmaceutical industry’s growth and demand for innovative drug delivery systems. The Asia Pacific is expected to expand significantly from 2024 to 2032 with a CAGR of 7.31%, driven by increasing demand for pharmaceutical-grade gelatin and regulatory compliance. The Pharmaceutical Gelatin Market is experiencing growth due to increased healthcare spending, demand for nutraceuticals, and expansion of pharmaceutical manufacturing in countries like China and India. Initiatives for affordable healthcare in the region are creating opportunities for gelatin-based applications, driving market growth. Darling Ingredients introduced Nextida™ GC collagen peptide for pharmaceutical use in 2024, while Alsiano partnered with Trobas Gelatine BV to enhance gelatin supply in Nordic markets. Key developments in the market include statistical insights, trends reporting, and competitive landscape analysis. S&S Insider offers market research and consulting services to provide clients with the knowledge needed to navigate changing circumstances and make informed decisions based on current market data and consumer insights.



Read more at GlobeNewswire: Pharmaceutical Gelatin Market to Reach USD 2.79 Billion,